• About
  • Technology
  • Pipeline
  • News & Events
  • Careers
  • Contact
  • Menu Menu

News & Events

Stay Up-to-Date with Glympse

Publications June 22, 2022

EASL ILC 2022 | Novel and accurate measurement of differential protease activity in diagnosed HCC patients compared to non-HCC cirrhotic patients

Read more
Publications June 22, 2022

EASL ILC 2022 | Measurement of Protease Activity Using Novel Plasma Biosensors Can Accurately Detect HCC from Healthy Controls

Read more
In the News June 10, 2022

BioWorld | Glympse diagnostic detects HCC in blood

Read more
Press Releases June 8, 2022

Glympse to Present Two Posters Demonstrating Novel Protease Biosensor Diagnostic Platform Detection of Hepatocellular Carcinoma at EASL ILC 2022

Read more
Press Releases May 17, 2022

Glympse Appoints Jonathan Wilde, Ph.D., as Chief Scientific Officer to Advance Biosensor Assay Platform

Read more
In the News May 13, 2022

Drug Discovery News | Goodbye biopsies, non-invasive diagnostics for fatty liver disease are here

Read more
In the News May 5, 2022

Medsider Podcast | 4 Key Considerations to Win Over Investors: Interview with Glympse Bio CEO Caroline Loew

Read more
In the News May 3, 2022

The LiverWELL Podcast | Dr. Tram Tran: Some good news about diagnosing NASH

Read more
In the News March 9, 2022

The Medtech Podcast | Non-Invasive Biosensor Technology with Caroline J. Loew, Organic Chemistry, Disease Trajectories, Growing a Business Through a Pandemic and Advice for Startups

Read more
  • 1
  • 2
  • 3
  • …
  • 10
  • ›
Loading...

35 Cambridgepark Drive
Suite 100
Cambridge, MA 02140

info@glympsebio.com

  • About
  • Technology
  • Pipeline
  • News & Events
  • Careers
  • Contact

© 2022 Glympse Bio. All rights reserved.

Terms of Use | Privacy Policy | Other Policies

Design and development by RainCastle Communications.

Images by Liz Linder Photography.